Adult Stem Cell Treatment of Scleroderma

Alan Tyndall; Daniel E. Furst


Curr Opin Rheumatol. 2007;19(6):604-610. 

In This Article

Allogeneic Hematopoietic Stem Cell Transplantation

Less is known about this more toxic treatment option, personal communication (GvHD) being a known complication. Three cases are reported, all receiving a reduced intensity nonmyeloablative HSCT.[16,21] In two, a successful response was seen and in a third, TRM occurred at about 1 year from complications relating to acute GvHD. A multidisciplinary consensus group recently published guidelines for allogeneic HSCT in autoimmune disease in general.[22]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.